FTC Asks Court to Dismiss Antitrust Claims Against Par, Paddock
The FTC is asking a Georgia federal court to remove Par Pharmaceuticals and Paddock Laboratories from an antitrust case that alleges the companies delayed the market entry of their AndroGel generics in exchange for payments.
Source: Drug Industry Daily